Literature DB >> 2377743

Renal uptake and excretion of epidermal growth factor from plasma in the rat.

P E Jørgensen1, T N Rasmussen, P Skov Olsen, L Raaberg, S Seier Poulsen, E Nexø.   

Abstract

The rat excretes around 2 nmol epidermal growth factor (EGF) in the urine per 24 h. The urinary EGF might be derived from plasma and/or might be synthesized in the kidneys. We have used the rat to study the renal uptake and excretion of homologous EGF from plasma. I.v. injected 125I-EGF was removed from the circulation within a few minutes. 5 min after the injection, the kidneys contained 12% of the 125I-EGF. The kidneys seemed to degrade most of the 125I-EGF which they accumulated from blood, as only 4% of the injected label was excreted as intact 125I-EGF in the urine. The amount of endogenous EGF in plasma was under the detection limit of our enzyme-linked immunosorbent assay (0.03 nmol/l) and it remained so after bilateral nephrectomy. Even if plasma EGF was 0.03 nmol/l excretion of EGF from plasma could account for less than 5% of the urinary EGF. This study shows that the kidneys are able to accumulate EGF from plasma and excrete a part of it as intact EGF in the urine. However, excretion of immunoreactive EGF from plasma can only account for a minor part of the urinary EGF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2377743     DOI: 10.1016/0167-0115(90)90025-r

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

1.  Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes.

Authors:  James M Mullin; James M Leatherman; Mary Carmen Valenzano; Erika Rendon Huerta; Jon Verrechio; David M Smith; Karen Snetselaar; Mantao Liu; Mary Kay Francis; Christian Sell
Journal:  Mol Biol Cell       Date:  2005-09-21       Impact factor: 4.138

Review 2.  Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Authors:  Helena M Kok; Lucas L Falke; Roel Goldschmeding; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2014-10-14       Impact factor: 28.314

3.  Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat.

Authors:  L Vinter-Jensen; M Smerup; P E Jørgensen; C O Juhl; T Orntoft; S S Poulsen; E Nexø
Journal:  Urol Res       Date:  1996

4.  Transmucosal gastric leak induced by proton pump inhibitors.

Authors:  Lisa J Murray; Melissa Gabello; David S Rudolph; Christopher P Farrell; Melissa Morgan; Aaron P Martin; James C Underwood; M Carmen Valenzano; James M Mullin
Journal:  Dig Dis Sci       Date:  2008-11-18       Impact factor: 3.199

5.  Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates.

Authors:  L Vinter-Jensen; C O Juhl; J C Djurhuus; S S Poulsen; E Z Dajani; K D Brown; T F Orntoft; P S Teglbjaerg; E Nexø
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

6.  Meta-Analysis and Bioinformatics Detection of Susceptibility Genes in Diabetic Nephropathy.

Authors:  Maria Tziastoudi; Christos Cholevas; Theoharis C Theoharides; Ioannis Stefanidis
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.